Pharmaceutical player GlaxoSmithKline is laying off hundreds of workers in its American facilities, and the bulk of these job cuts are in Research Triangle Park.
The company filed a notice with the Department of Commerce indicating the cuts affect approximately 900 jobs. The layoffs are part of a plan to consolidate research and development efforts at two sites, one in the Philadelphia area and one in the United Kingdom. These cuts are part of a reorganization effort aiming to reduce expenses by $1.5 billion in the next three years.
Host Frank Stasio talks with Triangle Business Journal Reporter Jason deBruyn about the latest.
